Crinetics Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CRNX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

225,842

Value ($000)

10,513

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	10,513	0.0%	225,842	12/31/2025
2025 Q3	11/14/2025	9,067	0.0%	217,690	9/30/2025
2025 Q2	8/14/2025	9,629	0.0%	334,796	6/30/2025
2025 Q1	5/19/2025	11,658	0.0%	347,581	3/31/2025
2024 Q4	2/14/2025	16,631	0.0%	325,276	12/31/2024
2024 Q3	11/14/2024	13,886	0.0%	271,747	9/30/2024
2024 Q2	8/14/2024	11,689	0.0%	260,980	6/30/2024
2024 Q1	5/15/2024	9,915	0.0%	211,820	3/31/2024
2023 Q4	2/14/2024	2,248	0.0%	63,175	12/31/2023
2023 Q3	11/13/2023	1,868	0.0%	62,826	9/30/2023
2023 Q2	8/11/2023	221	0.0%	13,745	6/30/2023
2023 Q1	5/15/2023	221	0.0%	13,745	3/31/2023
2022 Q4	2/14/2023	477	0.0%	26,066	12/31/2022
2022 Q3	11/14/2022	512	0.0%	26,066	9/30/2022
2022 Q2	8/12/2022	256	0.0%	13,745	6/30/2022
2022 Q1	5/16/2022	330	0.0%	15,021	3/31/2022
2021 Q4	2/14/2022	653	0.0%	22,972	12/31/2021
2021 Q3	11/15/2021	340	0.0%	16,140	9/30/2021
2021 Q2	8/16/2021	304	0.0%	16,140	6/30/2021
2021 Q1	5/14/2021	222	0.0%	14,503	3/31/2021
2020 Q4	3/1/2021	205	0.0%	14,503	12/31/2020
2020 Q3	11/13/2020	165	0.0%	10,503	9/30/2020
2020 Q2	8/14/2020	583	0.0%	33,254	6/30/2020